Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15601-15650 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03396601
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
PHASE3Active, not recruiting
150 participants
Started: Jun 25, 2019 · Completed: Dec 31, 2024
2 conditions2 sponsors2 locations
NCT03937219
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
PHASE3Active, not recruiting
855 participants
Started: Jun 25, 2019 · Completed: Jan 31, 2027
1 condition1 sponsor159 locations
NCT04860947
Assessment of NfL and GFAP Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS Patients
N/AActive, not recruiting
200 participants
Started: Jun 25, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT03941314
A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
NAActive, not recruiting
300 participants
Started: Jun 25, 2019 · Completed: Mar 31, 2026
1 condition3 sponsors3 locations
NCT04018638
Blood-Flow Restriction Exercise Following a Knee Replacement
NAActive, not recruiting
30 participants
Started: Jun 25, 2019 · Completed: Dec 25, 2025
3 conditions2 sponsors1 location
NCT04071691
PET Imaging of Giant Cell and Takayasu Arteritis
N/AActive, not recruiting
27 participants
Started: Jun 25, 2019 · Completed: Apr 30, 2025
2 conditions5 sponsors2 locations
NCT04007289
Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension
PHASE3Active, not recruiting
166 participants
Started: Jun 24, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03933735
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Active, not recruiting
220 participants
Started: Jun 24, 2019 · Completed: May 12, 2026
1 condition2 sponsors14 locations
NCT03190317
Health Information for Infected Veterans
N/AActive, not recruiting
123 participants
Started: Jun 24, 2019 · Completed: Sep 30, 2025
1 condition3 sponsors8 locations
NCT03876769
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
PHASE2Active, not recruiting
122 participants
Started: Jun 24, 2019 · Completed: Oct 19, 2027
1 condition2 sponsors45 locations
NCT03725007
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
PHASE1Active, not recruiting
124 participants
Started: Jun 24, 2019 · Completed: May 31, 2027
1 condition1 sponsor35 locations
NCT03366155
Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver
PHASE2Active, not recruiting
24 participants
Started: Jun 24, 2019 · Completed: Jan 31, 2027
5 conditions1 sponsor1 location
NCT03843294
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
PHASE1Active, not recruiting
18 participants
Started: Jun 24, 2019 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT03963349
THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study
N/AActive, not recruiting
150 participants
Started: Jun 24, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05133492
First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA)
NAActive, not recruiting
46 participants
Started: Jun 24, 2019 · Completed: Dec 31, 2026
3 conditions1 sponsor5 locations
NCT03999021
FIGHT-RP 1 Extension Study
PHASE1Active, not recruiting
30 participants
Started: Jun 24, 2019 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT03959098
Effectiveness and Safety of Korean Medicine Treatment for Cervical Disc Herniation
N/AActive, not recruiting
120 participants
Started: Jun 24, 2019 · Completed: Dec 1, 2027
3 conditions1 sponsor1 location
NCT03879447
Effectiveness and Safety of Korean Medicine for Low Back Pain or Sciatica Due to Lumbar Stenosis/spondylolisthesis
N/AActive, not recruiting
110 participants
Started: Jun 24, 2019 · Completed: Dec 31, 2027
5 conditions1 sponsor1 location
NCT03873402
A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
PHASE3Active, not recruiting
437 participants
Started: Jun 21, 2019 · Completed: Aug 29, 2025
1 condition1 sponsor78 locations
NCT03657641
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
PHASE1/PHASE2Active, not recruiting
75 participants
Started: Jun 21, 2019 · Completed: Jun 21, 2026
2 conditions2 sponsors3 locations
NCT03812393
Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast
PHASE2Active, not recruiting
27 participants
Started: Jun 21, 2019 · Completed: Dec 15, 2024
3 conditions3 sponsors1 location
NCT03996239
Researching the Effect of Aerobic Exercise on Cancer
NAActive, not recruiting
38 participants
Started: Jun 20, 2019 · Completed: Jun 30, 2026
1 condition3 sponsors10 locations
NCT03916419
Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
PHASE2Active, not recruiting
26 participants
Started: Jun 20, 2019 · Completed: Sep 25, 2025
4 conditions1 sponsor1 location
NCT04009681
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)
PHASE1/PHASE2Active, not recruiting
250 participants
Started: Jun 20, 2019 · Completed: Nov 30, 2025
1 condition1 sponsor24 locations
NCT03187340
Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults-2
NAActive, not recruiting
112 participants
Started: Jun 20, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03964233
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)
PHASE1Active, not recruiting
119 participants
Started: Jun 20, 2019 · Completed: May 30, 2026
1 condition1 sponsor23 locations
NCT04009343
Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials
PHASE2/PHASE3Active, not recruiting
182 participants
Started: Jun 19, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03853486
ATHN 9: Severe VWD Natural History Study
N/AActive, not recruiting
108 participants
Started: Jun 18, 2019 · Completed: Jul 30, 2026
1 condition2 sponsors22 locations
NCT03884660
remedē System Therapy Study
N/AActive, not recruiting
225 participants
Started: Jun 18, 2019 · Completed: Dec 30, 2030
1 condition1 sponsor32 locations
NCT03759938
OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial
NAActive, not recruiting
3,648 participants
Started: Jun 18, 2019 · Completed: Oct 31, 2024
2 conditions1 sponsor44 locations
NCT03851068
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
NAActive, not recruiting
40 participants
Started: Jun 18, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor5 locations
NCT04126525
Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
PHASE2Active, not recruiting
53 participants
Started: Jun 18, 2019 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT03765307
Bronchial Ablation for Treatment of Asthma (BATA) Trial
NAActive, not recruiting
160 participants
Started: Jun 18, 2019 · Completed: Dec 31, 2028
1 condition2 sponsors15 locations
NCT03946527
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
PHASE2Active, not recruiting
10 participants
Started: Jun 17, 2019 · Completed: Mar 31, 2026
2 conditions2 sponsors2 locations
NCT03604978
Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
PHASE1/PHASE2Active, not recruiting
38 participants
Started: Jun 17, 2019 · Completed: Nov 30, 2025
3 conditions1 sponsor29 locations
NCT03943875
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
PHASE4Active, not recruiting
757 participants
Started: Jun 17, 2019 · Completed: Mar 1, 2026
3 conditions2 sponsors1 location
NCT03944941
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer
PHASE2Active, not recruiting
60 participants
Started: Jun 17, 2019 · Completed: Dec 1, 2028
2 conditions2 sponsors428 locations
NCT03728985
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
NAActive, not recruiting
102 participants
Started: Jun 17, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor44 locations
NCT03895437
Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
PHASE2Active, not recruiting
78 participants
Started: Jun 17, 2019 · Completed: Sep 30, 2023
1 condition1 sponsor23 locations
NCT03283384
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
PHASE2Active, not recruiting
100 participants
Started: Jun 15, 2019 · Completed: Aug 31, 2027
1 condition3 sponsors29 locations
NCT06843031
The Role of Perfusion Index in Defining Postoperative Shivering
N/AActive, not recruiting
80 participants
Started: Jun 15, 2019 · Completed: Jun 15, 2025
3 conditions1 sponsor1 location
NCT04007809
Phenotypic and Genotypic Characterization of New-onset Type I Diabetes
NAActive, not recruiting
98 participants
Started: Jun 15, 2019 · Completed: Jun 30, 2027
1 condition3 sponsors1 location
NCT03735901
Enhancement of Stroke Rehabilitation With Levodopa
PHASE3Active, not recruiting
610 participants
Started: Jun 14, 2019 · Completed: Jun 30, 2029
2 conditions2 sponsors24 locations
NCT04000035
Health in Work - a Measure for Increased Coping and Work Inclusion
NAActive, not recruiting
1,383 participants
Started: Jun 14, 2019 · Completed: Jul 1, 2035
3 conditions4 sponsors1 location
NCT04017650
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
PHASE1/PHASE2Active, not recruiting
38 participants
Started: Jun 14, 2019 · Completed: Dec 30, 2025
16 conditions2 sponsors1 location
NCT03828227
QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.
PHASE3Active, not recruiting
49 participants
Started: Jun 14, 2019 · Completed: Dec 31, 2025
3 conditions1 sponsor22 locations
NCT03609047
Adjuvant Palbociclib in Elderly Patients With Breast Cancer
PHASE2Active, not recruiting
366 participants
Started: Jun 14, 2019 · Completed: Sep 30, 2032
2 conditions9 sponsors73 locations
NCT04173533
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
PHASE3Active, not recruiting
326 participants
Started: Jun 14, 2019 · Completed: Apr 30, 2025
2 conditions1 sponsor20 locations
NCT04764500
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
N/AActive, not recruiting
39 participants
Started: Jun 13, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03899792
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Jun 13, 2019 · Completed: May 31, 2029
5 conditions2 sponsors26 locations